ArticleBMJ open2026

The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of hormone-sensitive prostate cancer - study protocol.

Suzanne van der Gaag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.